Peggy B Leung 1 , Musarrat Nahid 2 , Melissa Rusli 2 , Diksha Brahmbhatt 2 , Fred N Pelzman 2 , Judy Tung 2 , Madeline R Sterling 2 Show Affiliations »
Abstract
INTRODUCTION: Disparities in access to video-visit services have been described during the COVID-19 pandemic. Thus, we aimed to examine factors associated with not having a video-visit among a medically high-risk ambulatory population. METHODS: In this cross-sectional study, our telephone-based survey was designed to understand the health-related challenges, social needs, and access to and attitudes toward video-visit. RESULTS: In the multivariable analysis, having fewer symptoms unrelated to COVID, more barriers to medications, and less confidence with video-visit software were significantly associated with an increased prevalence of not having a video-visit. CONCLUSIONS: Our findings suggest that additional efforts are needed to eliminate disparate video-visit use. © Copyright 2022 by the American Board of Family Medicine.
INTRODUCTION: Disparities in access to video-visit services have been described during the COVID-19 pandemic. Thus, we aimed to examine factors associated with not having a video-visit among a medically high-risk ambulatory population. METHODS: In this cross-sectional study, our telephone-based survey was designed to understand the health-related challenges, social needs, and access to and attitudes toward video-visit. RESULTS: In the multivariable analysis, having fewer symptoms unrelated to COVID, more barriers to medications, and less confidence with video-visit software were significantly associated with an increased prevalence of not having a video-visit. CONCLUSIONS: Our findings suggest that additional efforts are needed to eliminate disparate video-visit use. © Copyright 2022 by the American Board of Family Medicine.
Entities: Chemical
Keywords:
COVID-19; Chronic Disease; Cross-Sectional Studies; Disease Management; Multimorbidity; Pandemics; Primary Health Care; Telemedicine
Mesh： See more »
Year: 2022
PMID： 35641050 DOI： 10.3122/jabfm.2022.03.210483
Source DB: PubMed Journal: J Am Board Fam Med ISSN： 1557-2625 Impact factor: 2.395